Gene-editing biotech Metagenomi is preparing to go public and is working with the investment bank JP Morgan on a potential listing this fall, according to people familiar with the company’s plans.
If Metagenomi goes public, it would be one of only about a dozen biotech IPOs this year, though likely…
Click here to view original post
